Orthopedic Company Comes Under SEC Scrutiny
Law360 (November 21, 2006, 12:00 AM EST) -- Orthopedic products company ReGen Biologics Inc. said Monday that it has received a letter from the U.S. Securities and Exchange Commission’s Division of Enforcement requesting information regarding the company’s stock options-granting...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
